Alefacept in Patients With Severe Scalp Alopecia Areata
A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate The Safety and Therapeutic Efficacy of Intramuscular Administration of Alefacept in Patients With Chronic, Severe Scalp Alopecia Areata
Sponsor: National Alopecia Areata Foundation
Listed as NCT00167102, this NA trial focuses on Alopecia Areata and remains completed. Sponsored by National Alopecia Areata Foundation, it has been updated 12 times since 2005, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Nov 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2019 — Nov 2019 [monthly]
Completed NA
-
Jun 2018 — Jun 2019 [monthly]
Completed NA
-
Aug 2017 — Jun 2018 [monthly]
Completed NA
-
Feb 2017 — Aug 2017 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Jul 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Alopecia Areata Foundation
- University of Minnesota
For direct contact, visit the study record on ClinicalTrials.gov .